Literature DB >> 931202

Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients.

D A Goldstein, Y Oda, K Kurokawa, S G Massry.   

Abstract

The blood levels of 25-hydroxyvitamin D (25-HCC) in 26 patients with nephrotic syndrome (proteinuria of 6.5 g/24 h +/- 0.8 SEM) ranged between 1 and 18.6 ng/ml (8.6 +/- 1.0 SEM). This value was significantly lower (P less than 0.01) than that in normal subjects (21.8 +/- 2.3 ng/ml) and patients with chronic renal failure (24.8 +/- 2.3 ng/ml). There was inverse correlation (P less than 0.01) between levels of 25-HCC and magnitude of proteinuria and a direct relation (P less than 0.01) with serum albumin. Reduction in proteinuria was rapidly followed by a rise in blood 25-HCC toward normal. Ionized calcium levels were low in 16 of 26 nephrotic patients irrespective of degree of renal failure. In four of seven nephrotic patients with normal renal function, ionized calcium levels were low and showed an inverse relation with levels of parathyroid hormone. These data show that patients with nephrotic syndrome have low blood levels of 25-HCC probably due to its loss in urine. This derangement is probably responsible for the disorders of calcium metabolism in nephrosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 931202     DOI: 10.7326/0003-4819-87-6-664

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

Review 1.  Vitamin D deficient states. Pathophysiology and treatment.

Authors:  M D Jacobs
Journal:  West J Med       Date:  1979-10

2.  Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters.

Authors:  Gener Ismail; Gabriel Mircescu; Alecse Valerian Ditoiu; Beatrice Dorina Tacu; Roxana Jurubita; Mihai Harza
Journal:  Int Urol Nephrol       Date:  2014-04       Impact factor: 2.370

Review 3.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

4.  Serum 25 (OH) D and 24,25 (OH)2 levels in childhood nephrosis under different therapeutic regimens of steroid administration.

Authors:  K Kano; T Suda
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

5.  Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.

Authors:  H H Malluche; D A Goldstein; S G Massry
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

6.  Vitamin D status in Crohn's disease: association with nutrition and disease activity.

Authors:  A D Harries; R Brown; R V Heatley; L A Williams; S Woodhead; J Rhodes
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

7.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

8.  Monoclonal antibodies to human vitamin D-binding protein.

Authors:  E A Pierce; M C Dame; R Bouillon; H Van Baelen; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  A Grymonprez; W Proesmans; M Van Dyck; I Jans; G Goos; R Bouillon
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

10.  Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Authors:  David T Selewski; Ashton Chen; Ibrahim F Shatat; Priya Pais; Larry A Greenbaum; Pavel Geier; Raoul D Nelson; Stefan G Kiessling; Patrick D Brophy; Alejandro Quiroga; Michael E Seifert; Caroline E Straatmann; John D Mahan; Maria E Ferris; Jonathan P Troost; Debbie S Gipson
Journal:  Pediatr Nephrol       Date:  2015-10-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.